Dana Dominguez, MD retweeted
One exciting facet of @cityofhope's growth has been the development of a robust #TIL program. Proud to see @kmmahuron leading the charge for us. Tune in below to hear our terrific rising star in @CityofHopeSurg describe her vision for cell therapy in solid tumors! @SoCalYuman @ravisalgia @PercyLeeMD @DrSCohen @DanilovLab @MdBosserman @DrEdKim @CharlesMBrenner @COHurol @JuliusWengMD @yoonie_verse @HMcGeeMDPhD @AWalkerHealth
What does the tumor-infiltrating lymphocyte (TIL) therapy process look like from surgery to reinfusion?
Dr. Kelly Mahuron explains on tomorrow's episode of On the Edge of Breakthrough: Voices of Cancer Reasearch, with @montypal.
Subscribe and listen: bit.ly/4irhhhm
Congrats to Dr Labadie, future Dr Fan and the rest of the @cityofhope team for getting this out.
Preserved survival with lower doses 🟰 less toxicity for patients!
🆕article📰showing the value of the
LIVER PUMP⏺️
Hepatic arterial infusion (HAI) therapy for patients with resected colorectal cancer liver metastases (CRLM).
💡Reduced dosing leads to⬇️toxicity with preserved survival benefits.
@OncoAlert #CRCSM
link.springer.com/article/10…
Dana Dominguez, MD retweeted
14.3% rate (😮) of a tumor in those presenting with periappendiceal abscess. 52 of the 53 patients with tumors were over age 35.
Don’t skip out on the interval appy for adult patients with appendicitis! 🔪🔪🔪
This prospective cohort study confirmed high appendiceal tumor rate associated with periappendicular abscess especially in patients older than 35 years. ja.ma/3RuUllF
Dana Dominguez, MD retweeted
🚨 Exciting news for @AlamedaHealth System‼️We successfully performed our first TransCarotid Artery Revascularization (TCAR) procedure at Highland Hospital. Huge thanks to @UCSFvascular Surgeon & Asst. Professor Dr. Camille Jackson & the team for enhancing our vascular care🌟
Dana Dominguez, MD retweeted
The Impact of D2 Versus D1 #Lymphadenectomy in Siewert II Gastroesophageal Junction (GEJ) Cancer @nathanalcasidmd @JVelottaMD
rdcu.be/dUsdQ
@AnishJayJain
@SyedAAhmad5
Dana Dominguez, MD retweeted
You've heard of the nine circles of Hell? A patient with cancer documented the TWENTY-SIX steps necessary to get their medication (as an oncologist I know a vicious cycle when I see one)
Dana Dominguez, MD retweeted
Congratulations to our graduating Surgical Critical Care, Trauma and Acute Care Surgery Fellows. You all did a fantastic job during your time @ZSFGCare, @UCSFSurgery. You all have an exciting future ahead. @CRCollinsMD, @NicholeStarr5, Drs Beattie and Minko. Great work!
What these big databases are perfect for, ask good questions, get good answers! Another excellent work from @mtalhawaheed ! #NCDB
Excellent @SurgJournal contribution by @COH_SurgOnc @mtalhawaheed @AMBlakely @thinzarr @MustafaRaoofMD @AndreasMKaiser @laleh_melstrom @drmarkhanna surgjournal.com/article/S003…
Dana Dominguez, MD retweeted
‼️We are delighted to share the appointment of Dr. Genna Beattie as an Assistant Professor of Clinical Surgery, specializing in Trauma & Critical Care, effective this Fall. Dr. Beattie will be bringing her expertise to @UCSF_EastBay Surgery at Highland Hospital @AlamedaHealth🥳
Dana Dominguez, MD retweeted
🎙️Listen to the latest episode of SurgOnc Today discussing the management of synchronous rectal cancer with liver metastases with @AlexParikhMD, @laleh_melstrom, @timnewhook19, and @AndreasMKaiser.
surgonc.org/education/surgon…
Dana Dominguez, MD retweeted
‼️Dr. Brandon Cowan @branman_c has been awarded a sizable grant from the Mount Zion Health Fund! This funding bolsters his project on "What to do when things go wrong: A perfused model and simulation for high-volume hemorrhage control." @UCSFSkillsLab Congrats, Dr. Cowan 🎉🎉
Dana Dominguez, MD retweeted
Seems relevant to resurface Dr Andrew Ko’s observation at #asco23 that orders of magnitude separate the cost of NALIRIFOX vs FOLFIRINOX ‼️
BREAKING: @US_FDA Approves Frontline NALIRIFOX for Metastatic Pancreatic Adenocarcinoma #pancsm #oncology onclive.com/view/fda-approve…
Dana Dominguez, MD retweeted
Narrative review describes the use of liquid biopsy in making treatment decisions for patients with cancer, including in early-stage and resectable disease, and the potential to significantly improve care. ja.ma/3RR5BIR
This is a super important consideration, especially for surgical programs, 5-7 years is a LONG time and even if a family isn’t part of the plan going in life happens and plans change! You want to be somewhere that supports that!
Medical students strongly consider family planning when deciding on a residency, most consider how having a family might take away time from training. #ASC2024 @AcademicSurgery @WomenSurgeons
Excellent presentation, #SophiaDittrich! @MCWSurgery @MedicalCollege
6
427
Dana Dominguez, MD retweeted
Organ Preservation and Survival by Clinical Response Grade in Pts With Rectal Cancer Treated With Total Neoadjuvant Therapy: Secondary Analysis of the OPRA Randomized Clinical Trial @JAMAOnc @CathyEngMD @HKennecke @smitha42 jamanetwork.com/journals/jam…
Dana Dominguez, MD retweeted
Another successful #CriticalCare #Trauma #match for @UCSF_EastBay . @cdb_md will be heading to @pennsurgery @UPennTrauma , @surgeryandthebay to @HarborTrauma @HarborUCLASurg , and @kmazz007 to @UTHealthSASurg . We are sooo proud of these @traumadoctors #futuretraumasurgeon
Congrats @craig_mandy !
Our latest study led by a super talented former fellow Mandy Craig @NCIResearchCtr and so many wonderful collaborators reveals clues of hepatobiliary lineage commitment among two main histological liver cancer types. sciencedirect.com/science/ar…
275
Dana Dominguez, MD retweeted
Our latest study led by a super talented former fellow Mandy Craig @NCIResearchCtr and so many wonderful collaborators reveals clues of hepatobiliary lineage commitment among two main histological liver cancer types. sciencedirect.com/science/ar…
Dana Dominguez, MD retweeted
Randomized Controlled Trial of Perioperative Telemonitoring of Patient Generated Health Data in Gastrointestinal Oncologic Surgery @MustafaRaoofMD @SoCalYuman @AndreasMKaiser @KristenLimbach @VirginiaSunPhD link.springer.com/article/10…










































